Cytokinetics Inc. buy Citigroup Inc.
Start price
07.02.25
/
50%
€43.80
Target price
07.02.26
€82.96
Performance (%)
18.72%
Price
07:41
€52.00
Summary
This prediction is currently active. The prediction currently has a performance of 18.72%. This prediction currently runs until 07.02.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -5.357% | -5.357% |
| iShares Core DAX® | 0.323% | 2.208% |
| iShares Nasdaq 100 | 0.145% | -0.987% |
| iShares Nikkei 225® | 0.091% | -1.421% |
| iShares S&P 500 | 0.371% | -0.469% |
Comments by Citigroup_Inc_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $86.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat